Document is current

Any future updates will be listed below

Comparative efficacy and safety of rituximab, tocilizumab, and teprotumumab in Graves’ orbitopathy: a systematic review and meta-analysis

Crossref DOI link: https://doi.org/10.1038/s41433-025-03845-8

Published Online: 2025-05-22

Published Print: 2025-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark